CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 177 filers reported holding CARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $94,202 | -32.0% | 33,287 | +17.9% | 0.01% | -40.0% |
| Q1 2023 | $138,604 | +207.6% | 28,229 | +572.9% | 0.01% | +233.3% |
| Q4 2022 | $45,054 | +60.9% | 4,195 | +79.9% | 0.00% | +50.0% |
| Q1 2022 | $28,000 | -82.5% | 2,332 | -82.3% | 0.00% | -84.6% |
| Q4 2021 | $160,000 | +416.1% | 13,146 | +497.8% | 0.01% | +550.0% |
| Q2 2021 | $31,000 | -53.0% | 2,199 | -28.2% | 0.00% | -66.7% |
| Q1 2021 | $66,000 | +6500.0% | 3,062 | +3982.7% | 0.01% | – |
| Q4 2020 | $1,000 | -96.0% | 75 | -96.2% | 0.00% | -100.0% |
| Q3 2020 | $25,000 | -83.9% | 1,970 | -79.6% | 0.00% | -80.0% |
| Q4 2019 | $155,000 | +109.5% | 9,659 | +147.8% | 0.02% | +200.0% |
| Q2 2018 | $74,000 | +469.2% | 3,898 | +294.5% | 0.01% | +400.0% |
| Q3 2017 | $13,000 | -89.5% | 988 | -85.4% | 0.00% | -92.3% |
| Q1 2017 | $124,000 | +490.5% | 6,783 | +94.9% | 0.01% | +333.3% |
| Q1 2016 | $21,000 | – | 3,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |